Aurobindo Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.1%1-day move

₹1339.00

prior close

₹1345.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0-0.3+0.2+0.6+0.1+2.7+3.6+3.4+2.0+6.3+6.8+10.5+9.0+16.9

Up moveDown movePending

AI summary

Aurobindo Pharma has submitted a quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ending March 31, 2026. The filing confirms that details of securities dematerialized and rematerialized during the period were properly provided to both depositories (NSDL and CDSL) and all relevant stock exchanges where the company's shares are listed. The certificate was issued by the company's Registrar and Share Transfer Agent, KFin Technologies Limited, dated April 1, 2026. This is a mandatory routine filing for all listed companies and does not contain any specific transaction volumes or unusual activity details.

Likely market impact

No direct impact on stock price or shareholder value. This is a standard regulatory compliance filing confirming proper handling of dematerialization requests during the quarter.